SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0000950103-17-002421
Filing Date
2017-03-14
Accepted
2017-03-14 06:43:31
Documents
18
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F dp73891_20f.htm 20-F 1652278
2 EXHIBIT 4.7 dp73891_ex0407.htm EX-4.7 15025
3 EXHIBIT 4.8 dp73891_ex0408.htm EX-4.8 160210
4 EXHIBIT 12.1 dp73891_ex1201.htm EX-12.1 13594
5 EXHIBIT 12.2 dp73891_ex1202.htm EX-12.2 13755
6 EXHIBIT 13.1 dp73891_ex1301.htm EX-13.1 5399
7 EXHIBIT 13.2 dp73891_ex1302.htm EX-13.2 5829
8 EXHIBIT 15.1 dp73891_ex1501.htm EX-15.1 4224
9 GRAPHIC ex0407_logo.jpg GRAPHIC 5290
10 GRAPHIC ex0408_logo.jpg GRAPHIC 8012
11 GRAPHIC p46.jpg GRAPHIC 47714
12 GRAPHIC p49.jpg GRAPHIC 145125
13 GRAPHIC p53a.jpg GRAPHIC 26916
14 GRAPHIC p53b.jpg GRAPHIC 23605
15 GRAPHIC p54.jpg GRAPHIC 28495
16 GRAPHIC p60.jpg GRAPHIC 31449
17 GRAPHIC p61a.jpg GRAPHIC 29014
18 GRAPHIC p61b.jpg GRAPHIC 22636
  Complete submission text file 0000950103-17-002421.txt   2379640
Mailing Address FALKNERSTRASSE 4 4001 BASEL V8 00000
Business Address FALKNERSTRASSE 4 4001 BASEL V8 00000 41 (0)61 201 13 50
Auris Medical Holding AG (Filer) CIK: 0001601936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36582 | Film No.: 17686877
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences